Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation

Mise à jour : Il y a 4 ans
Référence : NCT00295594

Femme et Homme

Extrait

To compare the efficacy and safety of two regimens containing tacrolimus and minimal steroids together with either monoclonal anti-IL2R antibodies (daclizumab) or mycophenolate mofetil.


Critère d'inclusion

  • Liver Transplantation


Liens